Bristol-Myers Squibb

YTD

ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.

CEO

Christopher S. Boerner

CEOChristopher S. Boerner

Employees

34,100

Employees34,100

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1933

Founded1933

Employees

34,100

Employees34,100

BMY Key Statistics

Market cap

97.38B

Market cap97.38B

Price-Earnings ratio

17.63

Price-Earnings ratio17.63

Dividend yield

5.19%

Dividend yield5.19%

Average volume

14.14M

Average volume14.14M

High today

$47.88

High today$47.88

Low today

$46.85

Low today$46.85

Open price

$46.99

Open price$46.99

Volume

10.49M

Volume10.49M

52 Week high

$63.33

52 Week high$63.33

52 Week low

$39.35

52 Week low$39.35

BMY News

Simply Wall St 6d

Bristol-Myers Squibb Showcases Breakthrough Oncology Data at ASCO 2025 Meeting

is advancing in oncology, as evidenced by its upcoming presentations at the 2025 ASCO Annual Meeting, which highlight its strong focus on cancer treatments. Thi...

Analyst ratings

71%

of 28 ratings

Buy

25%

Hold

71.4%

Sell

3.6%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.